Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Trimethylamine (TMA) is a short-chain tertiary aliphatic amine that is derived from the diet either directly from the consumption of foods high in TMA or by the intake of food high in precursors to TMA, such as trimethylamine-N-oxide (TMNO), choline and L-carnitine. The clinical significance of TMA may be related to its potential to contribute to neurological toxicity and 'uraemic breath' in patients with end-stage renal disease (ESRD). METHODS: Concentrations of TMA and TMNO in plasma from 10 healthy adults (not on haemodialysis) and 10 adults with ESRD undergoing haemodialysis (pre- and post-dialysis) were determined by gas chromatography-mass spectrometry. RESULTS: The concentrations of TMA and TMNO in pre-dialysis plasma (1.39+/-0.483 and 99.9+/-31.9 microM, respectively) were significantly (P<0.05) higher than the corresponding levels in healthy subjects (0.418+/-0.124 and 37.8+/-20.4 microM, respectively). However, there were no significant differences between post-dialysis and healthy subject plasma concentrations. In the ESRD patients, there was a significant (P<0.05) reduction in plasma TMA (from 1.39+/-0.483 to 0.484+/-0.164 microM) and TMNO (from 99.9+/-31.9 to 41.3+/-18.8 microM) during a single haemodialysis session. CONCLUSIONS: TMA and TMNO accumulate between haemodialysis sessions in ESRD patients, but are efficiently removed during a single haemodialysis session.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMAO is cleared by the kidney, and prior studies have reported TMAO is elevated in subjects with impaired renal function16–18.”
In the citing paper
“TMAO is cleared by the kidney, and prior studies have reported TMAO is elevated in subjects with impaired renal function16–18.”
In the citing paper
“Differences in characteristics and disease status of participants across studies might affect TMAO levels14, 27, 28 and therefore partly explain such inconsistency.”
From Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies (2017) · cites this paper as [28]
In the citing paper
“Serum concentration of TMAO was inversely associated with eGFR and was markedly higher in patients receiving dialysis (59,81); hemodialysis efficiently removed TMAO from blood (8).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [8]
In the citing paper
“Significantly higher concentrations of TMA and TMAO were noted in plasma from 15 patients with end-stage renal disease compared to 15 healthy counterparts (8).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [8]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Review on uremic toxins: Classification, concentration, and interindividual variability
Vanholder, R., For the European Uremic Toxin Work Group (EUTox), De Smet, R., Glorieux, G., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., De Deyn, P. P., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00924.x · Cited by 1,720
Bressolle, F., Bromet-Petit, M., & Audran, M. (1996) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(96)00088-6 · Cited by 400 · cited 2×
“These results were within reasonable limits for the measurement of endogenous compounds [10].”
BackgroundMethodLang, D., Yeung, C., Peter, R., Ibarra, C., Gasser, R., Itagaki, K., Philpot, R., & Rettie, A. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00218-4 · Cited by 303
Trimethylaminuria: the fish malodor syndrome.
Mitchell, S. C., & Smith, R. L. (2001) · PubMed · Cited by 249
Biochemical Profile of Uremic Breath
Simenhoff, M. L., Burke, J. F., Saukkonen, J. J., Ordinario, A. T., Doty, R., & Dunn, S. (1977) · New England Journal of Medicine · doi:10.1056/nejm197707212970303 · Cited by 246 · cited 3×
“TMA and TMNO are of clinical importance because of their possible contribution to neurotoxicity and ‘uraemic breath’ in patients with ESRD [ 7 ].”
BackgroundMethodResultInfluentialDietary Precursors of Trimethylamine in Man: A Pilot Study
Zhang, A. Q., Mitchell, S. C., & Smith, R. L. (1999) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00028-9 · Cited by 232 · cited 2×
“TMA may be derived from the diet either directly by the consumption of foods high in TMA, such as fish, or by the enterobacterial generation of TMA from food rich in trimethylamine-N -oxide (TMNO), choline or L -carnitine [1].”
BackgroundApproaches to Cancer Prevention Based on an Understanding of N-Nitrosamine Carcinogenesis
Hecht, S. S. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44168 · Cited by 198 · cited 3×
“N -nitrosodimethylamine does not elicit its carcinogenic effects directly, but requires metabolic activation in the liver, particularly by the cytochrome P450 2E1 isoenzyme, to form highly reactive alkylating intermediates that have the ability to methylate target organ DNA [18].”
BackgroundResultInfluentialThe metabolism of14C-labelled trimethylamine and its N-oxide in man
Al-waiz, M., Mitchell, S. C., Idle, J. R., & Smith, R. L. (1987) · Xenobiotica · doi:10.3109/00498258709043962 · Cited by 143
Mills, G. A., Walker, V., & Mughal, H. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(98)00542-8 · Cited by 103 · cited 1×
“The plasma samples were analysed for TMA and TMNO using SPME and GC–MS based on the methods described previously [8,9].”
MethodIncreased incidence of neoplasia in chronic renal failure (20-year experience)
Cengiz, K. (2002) · International Urology and Nephrology · doi:10.1023/a:1014489911153 · Cited by 90 · cited 1×
“Other studies have shown higher levels of N -nitrosodimethylamine in the gastrointestinal tract of patients with ESRD compared with healthy controls [16] and, therefore, its potential contribution to an increased incidence of cancer in ESRD patients [17] should be carefully examined.”
Cited by
Items 201–293 of 293
Breath analysis as promising indicator of hemodialysis efficiency
Grabowska-Polanowska, B., Miarka, P., Skowron, M., Chmiel, G., Pietrzycka, A., & Śliwka, I. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-1625-8 · Cited by 9
Yan, Y., Li, J., Xu, H., Yang, C., Li, G., Feng, Y., Wang, Q., Li, L., Wu, R., Sun, H., et al. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118996 · Cited by 9
Kazeminasab, S., Emamalizadeh, B., Khoubnasabjafari, M., & Jouyban, A. (2020) · Pharmaceutical Sciences · doi:10.34172/ps.2020.46 · Cited by 8
Müller-Wirtz, L. M., Kreuer, S., Volk, T. J., & Hüppe, T. (2019) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-019-0544-0 · Cited by 8
Sánchez-Niño, M. D., & Ortíz, A. (2014) · Clinical Kidney Journal · doi:10.1093/ckj/sfu099 · Cited by 11
“However, TMAO had been reported to be increased in Australian patients on haemodialysis not supplemented with L-carnitine and in the absence of fish ingestion for 48 h [25], and TMAO is considered a uraemic toxin [26].”
BackgroundIs L-Carnitine the Link between Red Meat and Heart Disease?
Clouatre, D. L. (2013) · Journal of Nutrition & Food Sciences · doi:10.4172/2155-9600.1000e119 · Cited by 8
“Individuals with normal kidney function have no difficulty in excreting TMA/TMAO [9].”
Background(2021) · doi:10.1101/2021.01.28.428430 · Cited by 7
Comparison of breath biomarker studies for early diagnosis of chronic kidney disease: a review
Wang, Y., Weng, H., Xu, D., & Zhang, S. (2025) · Journal of Breath Research · doi:10.1088/1752-7163/addc8a · Cited by 7
“The study by Bain et al [41] showed that plasma TMA concentrations in ESRD patients were significantly higher than those in HS before hemodialysis, but decreased after dialysis to levels comparable to HS.”
Plasma trimethylamine N-oxide concentration and all-cause mortality in kidney transplant recipients
Yepes-Calderón, M., Sanchez, F. M. D. C., Kremer, D., Knobbe, T. J., Neto, A. W. G., Connelley, M. A., Dullaart, R. P. F., Corpeleijn, E., de Borst, M. H., Bakker, S. J. L., et al. (2025) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaf071 · Cited by 7
Yang, P., Li, X., Yang, W., Lian, H., Li, Y., & Zhang, X. (2020) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.8965 · Cited by 7
Manasa, M. V., Sarala Devi, G., S., P. R. P., & Sreedhar, B. (2019) · Materials Research Express · doi:10.1088/2053-1591/ab55a2 · Cited by 7
Wang, Y., Qiu, L., Yu, J., Ma, W., Song, X., Zhang, M., Xie, Y., Liu, A., Sun, L., Meng, X., et al. (2026) · Rare Metals · doi:10.1002/rar2.70105 · Cited by 8
Jiang, J., Zhu, P., Ding, X., Zhou, L., Lei, Y., Lei, Y., Wang, H., Chen, L., Li, X., Fei, Y., et al. (2025) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-025-13481-7 · Cited by 6
“It was reported that pre-dialysis plasma TMAO levels (99.9 ± 31.9 mM) were significantly higher than those in healthy subjects (37.8 ± 20.4 mM), although no significant difference was observed between post-dialysis patients and healthy controls regarding TMAO levels (Bain et al. 2006).”
InfluentialHumphries, T. L. R., Vesey, D. A., Galloway, G. J., Gobe, G. C., & Francis, R. S. (2023) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2023.04.001 · Cited by 8
Pyatchenkov, M. O., Vlasov, A. A., Sherbakov, E. V., & Salikova, S. P. (2023) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2023-33-3-7-15 · Cited by 6
Maksymiuk, K. M., Szudzik, M., Samborowska, E., Chabowski, D. S., Konop, M., & Ufnal, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297474 · Cited by 7
“Numerous studies have consistently demonstrated that impaired kidney function is associated with elevated plasma levels of TMA and TMAO [7, 65, 70, 74].”
Lei, Y., Jiang, J., Chen, L., Fang, Q., Li, C., Fei, Y., Qu, S., Xia, Z., Ning, Y., He, M., et al. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04625-y · Cited by 5
Valdivia‐Garcia, M., Bi, Y., Abaakil, K., & Li, J. V. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.116480 · Cited by 5
Hemocompatibility of cyclodextrin-coated magnetic nanoparticles under uremic conditions
Sharaf, M. G., Li, S., Rowe, E. M., Ali-Mohamad, N., Shew, M., Devine, D. V., & Unsworth, L. D. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.123836 · Cited by 5
Shimizu, M., & Yamazaki, H. (2017) · The Journal of Toxicological Sciences · doi:10.2131/jts.42.485 · Cited by 6
Metabolic Synergy to Uremic Toxicity: A Tale of Symbiosis and Dysbiosis in CKD
Paul, R., & Raj, D. S. (2019) · Nephrology Self-Assessment Program · doi:10.1681/nsap.2019.18.4.1 · Cited by 5
Noel, S., Patel, S. K., White, J. R., Verma, D., Menez, S. P., Raj, D. S., Parikh, C. R., Rabb, H., & for the Kidney Precision Medicine Project (2025) · Comprehensive physiology · doi:10.1002/cph4.70058 · Cited by 5
“Interestingly, Clostridium asparagiforme is a well-known trimethylamine N-oxide (TMAO) producer, and increased TMAO levels have been associated with CKD and ESRD (Zixin et al. 2022; Bain et al. 2006; Xu et al. 2017).”
Effect of hydroxy-PEO chain density and uremic toxins on plasma protein adsorption
Pawar, A. S., Ghahremanzadeh, A., Sharaf, M. G., & Unsworth, L. D. (2024) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2024.135888 · Cited by 4
Classification and a List of Uremic Toxins
Neirynck, N., Smet, R. D., Schepers, E., Vanholder, R. C., & Glorieux, G. (2012) · Wiley eBooks · doi:10.1002/9781118424032.ch2 · Cited by 4
Albumin coatings for counteracting uremic metabolites effects on host responses to biomaterials
Sharma, I., Sharaf, M. G., Pawar, A. S., Lockwood, E. E., & Unsworth, L. D. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1704352 · Cited by 3
Effects of levocarnitine in hemodialysis patients
Takeuchi, M., Kiyohara, M., Machida, H., & Takeuchi, H. (2012) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.45.955 · Cited by 3
Huang, P.-Y., Lin, Y., Chen, Y.-H., Hung, S., Liou, H., Tsai, J., & Hsu, B. (2024) · Toxins · doi:10.3390/toxins16120523 · Cited by 3
“Since TMAO is a small, water-soluble molecule, it can readily pass through the dialyzer or peritoneal membrane, and a single hemodialysis session can effectively remove a substantial amount of TMAO [41].”
Development of materials and methodologies for microextraction techniques
Lan, H. (2019) · Helda - University of Helsinki Institutional Repository · Cited by 6
Blachier, F. (2023) · Springer eBooks · doi:10.1007/978-3-031-26322-4_5 · Cited by 2
Hassan, S. S. M., Kamel, A. H., & El‐Naby, H. A. (2018) · Electroanalysis · doi:10.1002/elan.201800456 · Cited by 2
Contractile effect of trimethylamine and trimethylamine‐n‐oxide on isolated human umbilical arteries
Ongun, M. C., Örgül, G., Çelık, Ç., & Barışkaner, H. (2023) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15656 · Cited by 3
“However, patients with conditions such as chronic kidney disease (CKD) may have higher TMAO levels (up to 160 μM) than healthy subjects.(34,35) In addition, Wen et al.”
BackgroundEffect of End-Tethered Methoxy-PEO Chain Density on Uremic Toxin Adsorption
Ghahremanzadeh, A., Sharaf, M. G., Tonelli, M. A., & Unsworth, L. D. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c01564 · Cited by 2
Evaluating Electrospun Polycaprolactone Fibers for Blood‐Contacting Applications
Kuddushi, M., Pawar, A. S., Sharaf, M. G., Unsworth, L. D., & Zhang, X. (2025) · Biopolymers · doi:10.1002/bip.23656 · Cited by 2
Dobre, M. A., Meyer, T. W., & Hostetter, T. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00014-0 · Cited by 4
Age-related microbiome metabolites alter RNA splicing and chromatin accessibility in the brainPreprint
Chakraborty, M., Shi, S. M., Porter, I. E., Richard, D. J., Marinov, G. K., Murthy, M. N., Moore, A. A., Blum, J. L. E., Natarajan, A., Jahng, J. W. S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.03.680371 · Cited by 4
Online hemodiafiltration (HDF) versus high-flux hemodialysis (hf-HD): A review
Santos, A. F., da Cunha, R. S., Stinghen, A. E. M., & de Souza, W. M. (2022) · Research Society and Development · doi:10.33448/rsd-v11i4.27237 · Cited by 1
“This group includes creatinine (113 Da), urea (60 Da), trimethylamine N-oxide (TMAO; 75 Da), phenylacetylglutamine (264 Da), and guanidine (59 Da), among others (Bain et al., 2006; Poesen et al., 2016).”
BackgroundOgbuabor̽, A. O., Amadi, M. N., & Ugwuoke, M. C. (2025) · Journal of Hematology and Allied Sciences · doi:10.25259/jhas_3_2024 · Cited by 1
Ovalı, F., Vatansev, H., & Akyürek, F. (2026) · Genel Tıp Dergisi · doi:10.54005/geneltip.1549005 · Cited by 1
Trimethyllysine as a potential biomarker for heart failure
Lei, Y., Fang, Q., Wu, Q., Xiong, G., Jiang, J., Wu, Y., Chen, L., Ouyang, D., Li, Z., & Li, X. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121027 · Cited by 1
L-CARNITINE SUPPLEMENTATION IN UREMIC PATIENTS (LETTER TO EDITOR)
Zohreh, R., & Nemati, E. (2011) · Nephro-Urology Monthly · Cited by 1
Dobre, M. A., Meyer, T. W., & Hostetter, T. H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00008-1 · Cited by 2
Hüppe, T., Volk, T. J., & Kreuer, S. (2018) · Journal of Breath Research · doi:10.1088/1752-7163/aae210 · Cited by 1
Effect of Uremic Toxins and Methoxy-PEO Chain Density on Plasma Protein Adsorption
Pawar, A. S., Ghahremanzadeh, A., Sharaf, M. G., & Unsworth, L. D. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c01407 · Cited by 1
Design and Implementation of Analytical Mathematics for SIFT-MS Medical Applications
Moorhead, K. T. (2009) · UC Research Repository (University of Canterbury) · doi:10.26021/2316 · Cited by 1
Assessment of Optimal Egg Intake in a Healthy Population
DiMarco, D. M. (2017) · OpenCommons at University of Connecticut (University of Connecticut)
A Resonant Capacitive Test Structure for Biomolecule Sensing
Bane, D. (2015) · OhioLink ETD Center (Ohio Library and Information Network)
Bruzell, E. M., Steffensen, I., Granum, B. B., Hetland, R. B., Husøy, T., Rohloff, J., & Wicklund, T. (2015) · BIBSYS Brage (BIBSYS (Norway)) · doi:10.13140/rg.2.2.34736.87044 · Cited by 2
Sokolowicz, C. C., Peres, L. A., & Santos, S. (2003) · Ciência e Natura · doi:10.5902/2179460x27237
Role of Hepatic PEMT and Dietary Choline in the Development of Atherosclerosis
Zia, Y. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3736mj2x
Review: Uremic Toxins and Gut Microbiome
Suzuki, T., & Abe, T. (2020) · Springer eBooks · doi:10.1007/978-981-15-7793-2_2
Uremic Toxin-Related Systemic Disorders
Yamamoto, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-7793-2_4
Branched-chain amino acids and trimethylamine N-oxide as biomarkers of cardiometabolic outcomes
Flores-Guerrero, J. L. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.192215052
Gruber, M. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-54640-2_19
Trimetylamin N-oksid: En ny biomarkør for hjerte- og karsykdommer?
Olsen, T. (2016) · Norsk tidsskrift for ernæring · doi:10.18261/ntfe.14.1.10
THE ROLE OF THE INTESTINAL MICROBIOTA METABOLITE TMAO IN THE PATHOGENESIS OF VARIOUS DISEASES
Samoilova-Bedych, N., Laryushina, Е. М., Marchenko, A., & Сейсенбекова, А. К. (2024) · Farmaciâ Kazahstana · doi:10.53511/pharmkaz.2024.25.65.015 · Cited by 1
Ozkan, M. H. (2024) · Fabad Journal of Pharmaceutical Sciences · doi:10.55262/fabadeczacilik.1429111
“Essentially level of both metabolites in the circulatory system increases in patients having renal dysfunction or trimethylaminuria (Treacy, Aker-man, Chow, Youil, Bibeau, Lin,... Forrest, 1998; Bain, Faull, Fornasini, Milne, & Evans, 2006).”
BackgroundLi, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Figshare · doi:10.6084/m9.figshare.21564282
Li, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Figshare · doi:10.6084/m9.figshare.21564312
Li, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Figshare · doi:10.6084/m9.figshare.21564285
Hoyles, L., Pontifex, M. G., Rodríguez‐Ramiro, I., Anis-Alavi, M. A., Jelane, K. S., Snelling, T., Solito, E., Fonseca, S., Carvalho, A. L., Carding, S. R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17086980
Li, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Figshare · doi:10.6084/m9.figshare.21564309
Li, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Figshare · doi:10.6084/m9.figshare.21564279
Cirillo, A., Résimont, G., Massias, J., Guitton, Y., Jouret, F., Vidal‐Petiot, E., Flamant, M., Delanaye, P., & Tullio, P. D. (2024) · Research Square · doi:10.21203/rs.3.rs-4574552/v1
Mehta, R. J. (2024) · Clinical Diabetology · doi:10.5603/cd.102332
Transparent Janus Nanofibers for Use in Blood-Contact Applications
Kuddushi, M., Pawar, A. S., Sharaf, M. G., Unsworth, L. D., & Zhang, X. (2025) · Langmuir · doi:10.1021/acs.langmuir.5c00648
Sharma, I., Milley, A., Zhang, L., Zheng, J., Lockwood, E., Wishart, D. S., Tonelli, M. A., & Unsworth, L. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115366
Uremic metabolite adsorption to hydroxy-PEO thin films
Ghahremanzadeh, A., Sharaf, M. G., Tonelli, M. A., & Unsworth, L. D. (2025) · Surfaces and Interfaces · doi:10.1016/j.surfin.2025.107631
Maksymiuk, K. M., Szudzik, M., Gawryś-Kopczyńska, M., Onyszkiewicz, M., Samborowska, E., Mogilnicka, I., & Ufnal, M. (2022) · Figshare · doi:10.6084/m9.figshare.21343124
Maksymiuk, K. M., Szudzik, M., Gawryś-Kopczyńska, M., Onyszkiewicz, M., Samborowska, E., Mogilnicka, I., & Ufnal, M. (2022) · Figshare · doi:10.6084/m9.figshare.21343115
Li, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Figshare · doi:10.6084/m9.figshare.21564303
Maksymiuk, K. M., Szudzik, M., Gawryś-Kopczyńska, M., Onyszkiewicz, M., Samborowska, E., Mogilnicka, I., & Ufnal, M. (2022) · Figshare · doi:10.6084/m9.figshare.21343118
Vyas, U. N. (2024) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/5nee-jz06
Li, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Figshare · doi:10.6084/m9.figshare.21564300
Maksymiuk, K. M., Szudzik, M., Gawryś-Kopczyńska, M., Onyszkiewicz, M., Samborowska, E., Mogilnicka, I., & Ufnal, M. (2022) · Figshare · doi:10.6084/m9.figshare.21343121
Wiese, G. N. (2019) · Purdue e-Pubs (Purdue University System) · doi:10.25394/pgs.8980322
Maksymiuk, K. M., Szudzik, M., Gawryś-Kopczyńska, M., Onyszkiewicz, M., Samborowska, E., Mogilnicka, I., & Ufnal, M. (2022) · Figshare · doi:10.6084/m9.figshare.21343127
Li, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Figshare · doi:10.6084/m9.figshare.21564291
Li, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Figshare · doi:10.6084/m9.figshare.21564297
Li, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Figshare · doi:10.6084/m9.figshare.21564294
Li, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Figshare · doi:10.6084/m9.figshare.21564306
Hoyles, L., Pontifex, M. G., Rodríguez‐Ramiro, I., Anis-Alavi, M. A., Jelane, K. S., Snelling, T., Solito, E., Fonseca, S., Carvalho, A. L., Carding, S. R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17086974
Li, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Figshare · doi:10.6084/m9.figshare.21564288
Maksymiuk, K. M., Szudzik, M., Gawryś-Kopczyńska, M., Onyszkiewicz, M., Samborowska, E., Mogilnicka, I., & Ufnal, M. (2022) · Figshare · doi:10.6084/m9.figshare.21343112
Cirillo, A., Résimont, G., Massias, J., Guitton, Y., Jouret, F., Vidal‐Petiot, E., Flamant, M., Delanaye, P., & Tullio, P. D. (2026) · Research Square · doi:10.21203/rs.3.rs-8620894/v1
Nakayama, N. (2026) · Springer eBooks · doi:10.1007/978-981-95-7797-2_9
Jin, L., Zhang, K., Chen, X., Luo, Z., Tong, Y., Zhang, H., Ling, J., & Zhang, M. (2026) · ACS Sensors · doi:10.1021/acssensors.6c01489
Gong, H., Chen, S., Huang, Z., Yuan, H., Ma, J., & He, X. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1739319
“It was confirmed that with the development of CKD, the decline in the capacity of renal filtration and the dysbiosis of the intestinal flora result in the accumulation of uremic toxins in vivo , which was consistent with the previous report (Bain et al., 2006; Fujii et al., 2018).”
Rajabi, E., Seyedi, Z. P., Ghamari, M., Mohammadzadeh, R., Mansouri, M., Götz, F., & Bostanghadiri, N. (2026) · Infectious Medicine · doi:10.1016/j.imj.2026.100290
Metadata
- Authors
- Bain, M. A., Faull, R., Fornasini, G., Milne, R. W., & Evans, A. M.
- Affiliations
- University of South Australia (AU)
- Corresponding author
- Bain, Marcus A.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-09
- Volume
- 21
- Issue
- 5
- Pages
- 1300-1304
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2117368544
- Cited by
- 282
- References
- 20
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 13 · 2023: 16 · 2022: 32 · 2021: 22 · 2020: 20 · 2019: 26 · 2018: 17 · 2017: 20 · 2016: 19 · 2015: 21 · 2014: 19 · 2013: 6 · 2012: 6
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nephrology Dialysis Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- trimethylamine, trimethylamine N-oxide, end-stage renal disease, hemodialysis, plasma accumulation, neurotoxicity, choline, L-carnitine, dialysis clearance
- MeSH terms
- Adult, Female, Follow-Up Studies, Renal Dialysis, Humans, Kidney Failure, Chronic, Kidney Function Tests, Male, Methylamines, Middle Aged, Probability, Reference Values, Sensitivity and Specificity, Severity of Illness Index, Biomarkers, Case-Control Studies, Disease Progression, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.